Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 11, 2015, Pages 1963-1972

  Calore, Elisabetta ^a   Marson, Piero ^a   Pillon, Marta ^a   Tumino, Manuela ^a   Tison, Tiziana ^a   Mainardi, Chiara ^a   De Silvestro, Giustina ^a   Rossin, Sara ^a   Franceschetto, Genny ^a   Carraro, Elisa ^a   Pescarin, Matilde ^a   Varotto, Stefania ^a   Destro, Roberta ^a   Gazzola, Maria Vittoria ^a   Basso, Giuseppe ^a   Messina, Chiara ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Acute graft versus host disease; Children; Extracorporeal photochemotherapy; Hematopoietic stem cell transplantation

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; MYELOABLATIVE AGENT;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; DISEASE COURSE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ITALY; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OVERALL SURVIVAL; PHOTOCHEMOTHERAPY; PROGNOSIS; PROGRESSION FREE SURVIVAL; PUVA; STEROID THERAPY; SURVIVAL RATE; SYSTEMIC THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; ACUTE DISEASE; ALLOTRANSPLANTATION; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; INFANT; MIDDLE AGED; PATHOLOGY; PHOTOPHERESIS; PRESCHOOL CHILD; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; UNRELATED DONORS;

ACUTE DISEASE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; PHOTOPHERESIS; RETROSPECTIVE STUDIES; STEROIDS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS;

EID: 84943453328     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.07.007     Document Type: Article

References (39)

1. Ferrara J.L., Levine J.E., Reddy P., Holler E. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
2. Jagasia M., Arora M., Flowers M.E., et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012, 119:296-307.
3. Dignan F.L., Clark A., Amrolia P., et al. Diagnosis and management of acute graft-versus-host disease. Br J Haematol 2012, 158:30-45.
4. Deeg H.J. How I treat refractory acute GVHD. Blood 2007, 109:4119-4126.
5. Alousi A.M., Weisdorf D.J., Logan B.R., et al. Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. Blood 2009, 114:511-517.
6. Westin J.R., Saliba R.M., De Lima M., et al. Steroid-refractory acute GVHD: predictors and outcomes. Adv Hematol 2011, 2011:601953.
7. Weisdorf D., Haake R., Blazar B., et al. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood 1990, 75:1024-1030.
8. Martin P.J., Schoch G., Fisher L., et al. A retrospective analysis of therapy for acute graft versus host disease: initial treatment. Blood 1990, 76:1464-1472.
9. Marshall S.R. Technology insight: ECP for the treatment of GvHD-can we offer selective immune control without generalized immunosuppression?. Nat Clin Pract Oncol 2006, 3:302-314.
10. Peritt D. Potential mechanisms of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006, 12:7-12.
11. Bladon J., Taylor P.C. Extracorporeal photopheresis: a focus on apoptosis and cytokines. J Dermatol Sci 2006, 43:85-94.
12. Goussetis E., Varela I., Tsirigotis P. Update on the mechanism of action and on clinical efficacy of extracorporeal photopheresis in the treatment of acute and chronic graft versus host disease in children. Transfus Apher Sci 2012, 46:203-209.
13. Bruserud O., Tvedt T.H., Paulsen P.Q., et al. Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies. Cancer Immunol Immunother 2014, 63:757-777.
14. Greinix H.T., Knobler R.M., Worel N., et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica 2006, 91:405-408.
15. Perfetti P., Carlier P., Strada P., et al. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. Bone Marrow Transplant 2008, 42:609-617.
16. Greinix H.T., Worel N., Knobler R. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 2010, 16:1747-1748.
17. Greinix H.T., Worel N., Just U., Knobler R. Extracorporeal photopheresis in acute and chronic graft-versus-host disease. Transfus Apher Sci 2014, 50:349-357.
18. Messina C., Locatelli F., Lanino E., et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003, 122:118-127.
19. Pierelli L., Perseghin P., Marchetti M., et al. Extracorporeal Photopheresis for the treatment of acute and chronic graft-versus-host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process. Transfusion 2013, 53:2340-2352.
20. Calore E., Calò A., Tridello G., et al. Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. Bone Marrow Transplant 2008, 42:421-425.
21. Ascioglu S., Rex J.H., De Pauw B., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7-14.
22. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995, 15:825-828.
23. Perseghin P., Marchetti M., Messina C., et al. Best practice recommendations in: (1) Peripheral blood stem cell mobilization and collection and (2) acute and chronic GvHD treatment using extracorporeal photopheresis. A joint effort from SIdEM (Società Italiana di Emaferesi e Manipolazione Cellulare) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo). Transfus Apher Sci 2013, 48:195-196.
24. Marubini E., Valsecchi M.G. Analyzing survival data from clinical trials and observational studies 1995, Wiley, Chichester.
25. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 1:945-956.
26. Flowers M.E., Apperley J.F., Van Besien K., et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008, 112:2667-2674.
27. Greinix H.T., Van Besien K., Elmaagacli A.H., et al. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis-results of a crossover randomized study. Biol Blood Marrow Transplant 2011, 17:1775-1782.
28. Rutella S., Valentini C.G., Ceccarelli S., et al. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD). Transfus Apher Sci 2014, 50:340-348.
29. Kanold J., Messina C., Halle P., et al. Update on extracorporeal photochemotherapy for graft-versus-host disease treatment. Bone Marrow Transplant 2005, 35:S69-S71.
30. Kanold J., Merlin E., Halle P., et al. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature. Transfusion 2007, 47:2276-2289.
31. Berger M., Pessolano R., Albiani R. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report. J Pediatr Hematol Oncol 2007, 29:678-687.
32. Perotti C., Del Fante C., Tinelli C., et al. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients. Transfusion 2010, 50:1359-1369.
33. Merlin E., Paillard C., Rochette E., et al. Extracorporeal photochemotherapy as second- or first-line therapy of acute GVHD?. Bone Marrow Transplant 2010, 45:963-965.
34. De Silvestro G., Bagatella P., Vicarioto M., Tison T., Marson P. The Italian SIdEM registry for apheresis: an overview of the 2005 statistics. Int J Artif Organs 2008, 31:354-362.
35. Bacigalupo A. Management of acute graft-versus-host disease. Br J Haematol 2007, 137:87-98.
36. Schneiderman J., Jacobsohn D.A., Collins J., Thormann K., Kletzel M. The use of fluid boluses to safely perform extracorporeal photopheresis (ECP) in low-weight children: a novel procedure. J Clin Apher 2010, 25:63-69.
37. Rocha V., Wagner J.E., Sobocinski K.A., et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000, 342:1846-1854.
38. Meisel R., Laws H.J., Balzer S., et al. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies. Biol Blood Marrow Transplant 2007, 13:1338-1345.
39. Zecca M., Prete A., Rondelli R., et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 2002, 100:1192-1200.